July 8, 2021
In response to the Federal Trade Commission’s Multilateral Pharmaceutical Merger Task Force Request for Public Comment on competition and merger analysis, Intensity, LLC* was one of 46 comments to be featured by the government taskforce. Managing Director Richard Manning, Ph.D., collaborated with fellow economists Kira Stearns, Ph.D., Kyle Kost, Ph.D., and Richard Brady, Ph.D., to address pricing concerns in the industry.
To download and read the full comment posted by the FTC, please click on the following link: Comment to Multilateral Pharmaceutical Task Force.
*The comment is in response to the Multilateral Pharmaceutical Task Force’s Request for Public Comment. The views expressed therein represent those of the authors and not those of Secretariat or of any other members of the firm. Intensity, LLC was acquired by Secretariat in February 2023.
AI Reckoning and Sustainability Challenges Drive Consultants’ Predictions for 2025
As we step into 2025, the fight against fraud in the UK is evolving, with a spotlight on whistle-blower incentivization. Director Ben Boorer highlights critical developments in the UK’s corporate compliance landscape in an article for Consultancy UK.
Nine Secretariat Experts Honored with Lexology Index 2025 Client Choice Award for Expert Witnesses
We are pleased to announce that nine of our experts were awarded the 2025 Lexology Index Client Choice Award for Expert Witnesses.
Secretariat Secures No. 1 Spot on Lexology Index’s Arbitration 2025 Report
We are proud to announce that Secretariat has earned the position of No. 1, top-ranked Consulting Expert Firm in the Lexology Index Arbitration 2025 report. The report features firms and experts who have distinguished themselves as industry leaders based on their independence, sharp testifying skills, clear communications, and meticulous analytical insights.